Orally deliverable pharmaceutical composition comprising a drug of low water solubility (COX-2 inhibitor), a solvent, a fatty acid and an organic amine

Details for Australian Patent Application No. 2002305175 (hide)

Owner Pharmacia Corporation

Inventors Gao, Ping; Forbes, James C.; Karim, Aziz; Hassan, Fred

Agent Griffith Hack

Pub. Number AU-B-2002305175

PCT Number PCT/US02/11689

PCT Pub. Number WO2002/083177

Priority 60/326,952 04.10.01 US; 60/284,381 17.04.01 US

Filing date 12 April 2002

Wipo publication date 28 October 2002

Acceptance publication date 12 July 2007

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/00 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/52 (2006.01)

A61K 31/63 (2006.01) - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide

A61K 31/635 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/326,952 04.10.01 US; 60/284,381 17.04.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002305175

12 July 2007 Application Accepted

  Published as AU-B-2002305175

8 November 2007 Standard Patent Sealed

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305176-METHOD OF FABRICATING AN OXIDE LAYER ON A SILICON CARBIDE LAYER UTILIZING AN ANNEAL IN A HYDROGEN ENVIRONMENT

2002305174-METHODS AND COMPOSITIONS FOR IDENTIFYING DISEASE GENES USING NONSENSE-MEDIATED DECAY INHIBITION